Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Technical Institute (UTI) Asset Writedowns and Impairment (2016 - 2024)

Universal Technical Institute (UTI) has disclosed Asset Writedowns and Impairment for 15 consecutive years, with -$5.1 million as the latest value for Q3 2024.

  • On a quarterly basis, Asset Writedowns and Impairment fell 250.1% to -$5.1 million in Q3 2024 year-over-year; TTM through Jun 2024 was $3.6 million, a 164.16% increase, with the full-year FY2022 number at $2.0 million, up 16.41% from a year prior.
  • Asset Writedowns and Impairment was -$5.1 million for Q3 2024 at Universal Technical Institute, down from $1.9 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.9 million in Q2 2024 to a low of -$5.1 million in Q3 2024.
  • A 5-year average of $180789.5 and a median of $560000.0 in 2021 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 2957.69% in 2022, then crashed 1779.22% in 2023.
  • Universal Technical Institute's Asset Writedowns and Impairment stood at $389000.0 in 2020, then skyrocketed by 43.96% to $560000.0 in 2021, then fell by 4.46% to $535000.0 in 2022, then surged by 177.76% to $1.5 million in 2023, then crashed by 440.92% to -$5.1 million in 2024.
  • Per Business Quant, the three most recent readings for UTI's Asset Writedowns and Impairment are -$5.1 million (Q3 2024), $1.9 million (Q2 2024), and $1.7 million (Q1 2024).